Paris Attacks Trial to Resume as Key Defendant Recovers from COVID-19

The hearings should normally resume this Tuesday, January 11. In their report, the infectious disease specialist and pulmonologist commissioned by the assize court chaired by Jean-Louis Périès concluded that Salah Abdeslam, "recovered" from a "moderate" Covid, is fit to appear, reports L’Obs. He had been diagnosed positive for the new coronavirus on December 27. The sole survivor of the commando of the deadly attacks "presented a moderately symptomatic SARS-CoV-2 infection that began on December 24, 2021," is "currently cured of this infection, with only moderate residual asthenia and intermittent dry cough," the experts point out, after examining the terrorist.

"Since January 3, 2022, in application of the most recent recommendations in force, he is medically and health-wise fit to attend the hearings of the assize court," they specify, adding that with regard to the infectious disease from which the main defendant in the November 13, 2015 attacks has been a carrier, no medical measure should be taken apart from symptomatic treatment, which has been prescribed to him. "Strict compliance with barrier measures is required of him upon the resumption of the hearings, but independently of the infection he has presented," the experts also point out.